Refining method of Pinefibrate intermediate

During the preparation process of the Pemabet intermediate, the purification, extraction and suction filtration of silica gel is replaced by silica gel through column processing, and the complexity and cost of the silica gel through column purification step in the prior art is solved, and the problem of high cost of silica gel through column purification step is achieved. It is suitable for industrial production with high purity and high yield.

CN118955421AActive Publication Date: 2024-11-15NANJING HEALTHNICE MEDICAL TECH +3

Patent Information

Application Number
CN202410928899.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-11
Publication Date
2024-11-15
Estimated Expiration
2044-07-11

AI Technical Summary

Technical Problem

In the existing preparation method of Pemabet intermediate, the silica gel is subject to complex over-column purification steps and is not suitable for large-scale industrial production, resulting in high production costs, excessive solid waste and waste liquid production, and excessive use of silica gel is harmful to health. The purity and yield of the product are not high.

Method used

The silica gel is stirred and purified, extracted and filtration purified instead of silica gel through column, simplifying the post-treatment process, improving the yield and purity of the product, and is suitable for industrial production.

Benefits of technology

The yield and purity of the product are not less than 95%, reducing production costs, avoiding the generation of solid waste and waste liquid, suitable for large-scale production, and improving the safety and efficiency of the process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004939066580000011
    Figure BDA0004939066580000011
  • Figure BDA0004939066580000021
    Figure BDA0004939066580000021
  • Figure BDA0004939066580000031
    Figure BDA0004939066580000031
Patent Text Reader

Abstract

According to the refining method of the Pinefibrate intermediate, in the post-treatment process, silica gel is added for stirring purification and extraction and suction filtration purification replace two times of silica gel column passing for separation and purification, the post-treatment process is simple, the yield and purity of the product are high and are not lower than 97%, and the whole preparation method is simple and suitable for industrial production. The problem that a large amount of solid waste and waste liquid are inevitably generated due to separation and purification by two times of silica gel column passing is not required to be solved, the production cost can be greatly reduced, and the method is suitable for industrial large-scale production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of drug synthesis, and specifically relates to a method for refining a Pemabate intermediate, wherein the chemical name of the Pemabate intermediate is (R)-2-(3-(benzo[d]oxazol-2-yl(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxybutyric acid butyl ester. Background Art

[0002] Pemafibrate is a new, highly selective PPARα modulator developed by Kowa Company, and its structural formula is as follows. The drug binds to PPARα and regulates the expression of genes involved in lipid metabolism, thereby reducing triglyceride (TG) levels in the blood and increasing high-density lipoprotein cholesterol (HDL-C) levels. And related studies have shown that Pemafibrate has a significant effect on reducing triglycerides in fasting serum, can enhance the effect of HDL-C, and this effect is long-lasting. Previously, this drug has been approved in Japan for the treatment of hyperlipidemia (including familial hyperlipidemia). In July 2017, Pemafibrate ordinary tablets obtained the world's first marketing authorization from the Ministry of Health, Labor and Welfare of Japan. On June 26, 2023, Pemafibrate's new dosage form sustained-release tablets obtained the world's first marketing authorization from Japan PMDA for the treatment of hyperlipidemia (including familial hyperlipidemia). Compared with Pemafibrate tablets, which need to be taken twice a day, sustained-release tablets only need to be taken once a day. Pemabet is the world's first peroxisome proliferator-activated receptor α (PPARα) modulator to obtain market approval. It can improve the problem of low serum triglyceride levels by regulating liver lipid metabolism, and its safety is better than other fibrate lipid-lowering drugs. According to the ClinicalTrials clinical trial registration website, in addition to hyperlipidemia, Pemabet has three other indications (non-alcoholic fatty liver disease, type 2 diabetes, and hypercholesterolemia) in the clinical research stage.

[0003]

[0004] At present, the preparation of Pemabet generally adopts the preparation method disclosed in the original research patent, and its synthesis route is as follows:

[0005]

[0006] In the preparation method disclosed in the original patent, the preparation method of intermediate 3 is relatively complicated. First, the side chain compound generated by the reaction of compound SMD and trifluoromethanesulfonic anhydride needs to be purified by column in the original patent. Since the side chain compound is in an oily state, it is not easy to purify and has a greater impact on the next step, so it is purified by column in the original patent. Secondly, the intermediate 3 generated by the reaction of the side chain compound and intermediate 2 is also purified by column in the original patent to obtain a higher purity intermediate 3 product, namely (R)-2-(3-(benzo[d]oxazol-2-yl(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxybutyric acid butyl ester.

[0007] The steps for preparing intermediate 3 in the original patent have obvious shortcomings. The side chain compound prepared by compound SMD and trifluoromethanesulfonic anhydride cannot be monitored by point plate. The original patent records that the use of dichloromethane to flush the column requires a large amount of solvent and is difficult to operate. There is basically no absorption, which leads to blind collection of fractions, which is time-consuming and laborious. In addition, a large amount of silica gel is required for silica gel column, and it cannot be reused, which will produce a large amount of waste solid. Not only that, for the intermediate 3 generated by the reaction of the side chain compound with intermediate 2, n-heptane and ethyl acetate with a volume ratio of 2:1 are used as eluents for column column. The column is a glass column, and the filling material is 200-300 mesh silica gel. The entire column time is about 3h, and the amount of eluent used is found to be about 1000 times. At present, the laboratory can only accept about 100g of column purification, which makes this step unsuitable for large-scale production. In addition, column purification is rarely used in factories, further limiting its industrial application. Summary of the invention

[0008] The purpose of the present invention is to provide a method for refining a Pemabet intermediate on the basis of the prior art. In the process of post-treatment, silica gel is added for stirring purification, extraction and suction filtration purification, instead of two silica gel column separation and purification. The post-treatment process is simple, the yield and purity of the product are high, and the yield and purity are not less than 95%. The whole preparation method is simple, and there is no need to solve the problem of inevitably generating a large amount of solid waste and waste liquid due to two silica gel column separation and purification. The production cost can be greatly reduced, and it is suitable for industrial large-scale production. Among them, the chemical name of the Pemabet intermediate is (R)-2-(3-(benzo[d]oxazol-2-yl(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxybutyric acid butyl ester, and its structural formula is as follows:

[0009]

[0010] The technical solution of the present invention is as follows:

[0011] A method for refining a Pemabet intermediate comprises the following steps:

[0012] (1) Compound SMD is dissolved in dichloromethane, pyridine is added at -5 to 5°C, trifluoromethanesulfonic anhydride is added dropwise to the resulting mixture while stirring, and after the addition is complete, the stirring reaction is continued. After the reaction is completed, silica gel is added to the resulting reaction solution, and the stirring time is 10 to 60 minutes. The solution is filtered and spin-dried to obtain compound SME, which is dissolved in acetonitrile to prepare an acetonitrile solution containing compound SME;

[0013] (2) The intermediate 2, potassium carbonate and acetonitrile are uniformly mixed, and the acetonitrile solution containing the compound SME prepared in step (1) is added to the obtained mixture, and the mixture is stirred at room temperature for reaction. After the reaction is completed, water is added to the obtained reaction solution for quenching, extraction, washing, drying, suction filtration and concentration to obtain the intermediate 3. The specific synthetic route is as follows:

[0014] For the present invention, in step (1), the side chain compound SME prepared from the compound SMD and trifluoromethanesulfonic anhydride is stirred and purified by adding silica gel during the post-treatment process, which solves the problem of using silica gel for separation and purification. For example, during the column separation and purification, the product compound SME cannot be monitored by TLC and HPLC due to the lack of ultraviolet absorption, and a large amount of eluent needs to be used for column washing, otherwise the yield of the product will be reduced; in addition, too much silica gel in the adsorption column may cause adsorption decomposition, which also leads to a decrease in the yield of the product. When column chromatography separation is performed during the post-treatment process, the adsorption column needs to be filled with a large amount of silica gel, the amount of silica gel is high, and the silica gel cannot be reused, which will generate a large amount of solid waste when expanding production. During the experimental operation, it is avoided that silica gel is inhaled into the human body, and the use of a large amount of silica gel will affect human health. In addition, the amount of eluent is also high, and a large amount of waste liquid will be generated when expanding production. At present, the laboratory can only accept about 100g of crude product for column purification, and the separation method of column purification is rarely used in factories, further limiting its industrial application.

[0015] In a preferred embodiment, the mesh number of the silica gel is 200-300.

[0016] In the present invention, in step (1), during the post-treatment process, silica gel is added for stirring and purification, and the mass ratio of compound SMD to silica gel is 1:5-15, which can be but not limited to 1:5, 1:6, 1:7, 1:8, 1:9, 1:10, 1:11, 1:12, 1:13, 1:14 or 1:15. In a preferred embodiment, the mass ratio of compound SMD to silica gel is 1:8-12, and more preferably, the mass ratio of compound SMD to silica gel is 1:10.

[0017] In step (1), silica gel is added to the obtained reaction solution, and the stirring time is 30-60 min, which may be but is not limited to 30 min, 35 min, 40 min, 45 min, 50 min, 55 min or 60 min, and is preferably 30 min.

[0018] In a preferred embodiment, in step (1), pyridine is added at 0°C.

[0019] In a preferred embodiment, in step (1), the molar ratio of compound SMD to trifluoromethanesulfonic anhydride is 1:0.8-1.2, which may be but is not limited to 1:0.8, 1:0.9, 1:0.95, 1:1.0, 1:1.05, 1:1.1 or 1:1.2, and is preferably 1:1.0.

[0020] In a preferred embodiment, in step (1), the mass ratio of compound SMD to pyridine is 1:0.3-0.7, which may be but is not limited to 1:0.3, 1:0.35, 1:0.4, 1:0.45, 1:0.5, 1:0.52, 1:0.54, 1:0.5, 1:0.6 or 1:0.7, preferably 1:0.52.

[0021] In a preferred embodiment, in step (2), the molar ratio of compound SMD to intermediate 2 is 1:0.5-0.9, which may be but is not limited to 1:0.5, 1:0.55, 1:0.6, 1:0.65, 1:0.7, 1:0.75, 1:0.8, 1:8.5 or 1:0.9, preferably 1:0.7.

[0022] In a preferred embodiment, in step (2), the mass ratio of compound SMD to potassium carbonate is 1:0.6-1.2, which may be but is not limited to 1:0.6, 1:0.7, 1:0.8, 1:0.9, 1:0.95, 1:1.0, 1:1.1 or 1:1.2, and is preferably 1:0.9.

[0023] In a preferred embodiment, in step (2), the reaction time is 6-12 hours, preferably 8 hours.

[0024] In a preferred embodiment, in step (2), water is added to the obtained reaction solution to quench, and the solution is extracted with dichloromethane, washed with brine, dried over sodium sulfate, filtered and concentrated to obtain intermediate 3.

[0025] In the present invention, in step (2), the post-treatment process is simple, and the intermediate 3 is obtained by extraction with dichloromethane, washing with brine, drying with sodium sulfate, and filtering and concentrating. The product intermediate 3 does not need to be separated and purified by silica gel column as in the original patent. The post-treatment process is cumbersome and time-consuming, and when expanding production, a large amount of solid waste and waste liquid are inevitably generated, resulting in a significant increase in production costs, further limiting its industrial application.

[0026] Adopt the technical scheme of the present invention, the advantages are as follows:

[0027] The present invention provides a method for refining a Pemabet intermediate. In the process of post-treatment, silica gel is added for stirring purification, extraction and suction filtration purification instead of passing silica gel through a column twice for separation and purification. The post-treatment process is simple, and the yield and purity of the product are high, which are not less than 95%. The whole preparation method is simple, and there is no need to solve the problem of inevitably generating a large amount of solid waste and waste liquid due to separation and purification through a column twice for silica gel, so the production cost can be greatly reduced, and the method is suitable for industrial large-scale production. DETAILED DESCRIPTION

[0028] The present invention is further explained below by specific examples and comparative examples, but this is not intended to limit the present invention. Professionals and technicians in this field can make any modifications, equivalent substitutions or improvements based on the basic ideas of the present invention, which should all be included in the scope of the present invention.

[0029] Example 1

[0030] A method for refining a Pemabet intermediate (i.e., intermediate 3), comprising the following steps:

[0031] (1) Add 0.3 g of compound SMD (i.e., n-butyl (S)-2-hydroxybutyrate) and 5 ml of dichloromethane to a 50 ml three-necked flask in sequence, stir until dissolved, cool to 0° C., add 0.155 g of pyridine, and dropwise add 0.528 g of trifluoromethanesulfonic anhydride to the resulting mixture during stirring. After the dropwise addition is complete, continue stirring and reacting for 30 min. After the reaction is completed, add 3 g of 200-300 mesh silica gel to the resulting reaction solution, stir for 30 min, filter, and spin dry to obtain compound SME (i.e., n-butyl (S)-2-trifluoromethanesulfonyl hydroxybutyrate), which is dissolved in 10 ml of acetonitrile to prepare an acetonitrile solution containing compound SME;

[0032] (2) 0.53 g of intermediate 2 was added to 10 ml of acetonitrile, and then 0.272 g of potassium carbonate was added. After stirring, the acetonitrile solution containing compound SME prepared in step (1) was added to the resulting mixture, and the reaction was stirred at room temperature for 8 hours. After the reaction was completed, water was added to the resulting reaction solution to quench, and the mixture was extracted with dichloromethane, washed with brine, dried with sodium sulfate, and filtered and concentrated to obtain a colorless oil, namely intermediate 3 ((R)-2-(3-(benzo[d]oxazol-2-yl(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxybutyric acid butyl ester), with a yield of about 100% and a purity of 97.82%. The specific synthetic route is as follows:

[0033]

[0034] Example 2

[0035] A production of a Pemabet intermediate (i.e., intermediate 3), comprising the following steps:

[0036] (1) Add 3.6 kg of compound SMD (i.e., (S)-2-hydroxybutyric acid n-butyl ester) and 15 L of dichloromethane to a 50 L reactor in sequence, stir until dissolved, cool to 0°C, add 2.9 kg of pyridine, and dropwise add 7.64 kg of trifluoromethanesulfonic anhydride to the resulting mixture during stirring. After the dropwise addition is complete, continue stirring and reacting for 30 min. After the reaction is completed, add 36.0 kg of 200-300 mesh silica gel to the resulting reaction solution, stir for 30 min, filter with suction, and spin dry to obtain compound SME (i.e., n-butyl (S)-2-trifluoromethanesulfonyl hydroxybutyrate), which is dissolved in 10 L of acetonitrile to prepare an acetonitrile solution containing compound SME;

[0037] (2) 5.3 kg of intermediate 2 was added to 20 L of acetonitrile, and then 4.75 kg of potassium carbonate was added. After stirring, the acetonitrile solution containing compound SME prepared in step (1) was added to the obtained mixture, and the reaction was stirred at room temperature for 8 hours. After the reaction was completed, water was added to the obtained reaction solution to quench, and the mixture was extracted with dichloromethane, washed with brine, dried with sodium sulfate, centrifuged, and concentrated to obtain a colorless oil, which is intermediate 3 ((R)-2-(3-(benzo[d]oxazol-2-yl(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxybutyric acid butyl ester), with a yield of about 100% and a purity of 97.75%.

[0038] Example 3

[0039] (1) Add 0.3 g of compound SMD (i.e., n-butyl (S)-2-hydroxybutyrate) and 5 ml of dichloromethane to a 50 ml three-necked flask in sequence, stir until dissolved, cool to 0°C, add 0.155 g of pyridine, and dropwise add 0.528 g of trifluoromethanesulfonic anhydride to the resulting mixture during stirring. After the dropwise addition is complete, continue stirring and reacting for 30 min. After the reaction is completed, add 2.7 g (SMD: silica gel = 1:9) 200-300 mesh silica gel to the resulting reaction solution, stir for 30 min, filter, and spin dry to obtain compound SME (i.e., n-butyl (S)-2-trifluoromethanesulfonyl hydroxybutyrate), which is dissolved in 10 ml of acetonitrile to prepare an acetonitrile solution containing compound SME;

[0040] (2) 0.53 g of intermediate 2 was added to 10 ml of acetonitrile, and then 0.272 g of potassium carbonate was added. After stirring, the acetonitrile solution containing compound SME prepared in step (1) was added to the obtained mixture, and the reaction was stirred at room temperature for 8 hours. After the reaction was completed, water was added to the obtained reaction solution to quench the reaction, and the mixture was extracted with dichloromethane, washed with brine, dried with sodium sulfate, and filtered and concentrated to obtain a colorless oil, which is intermediate 3 ((R)-2-(3-(benzo[d]oxazol-2-yl(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxybutyric acid butyl ester), with a yield of about 100% and a purity of 97.05%.

[0041] Comparative Example 1 (Original Research)

[0042] (1) Add 0.3 g of compound SMD (i.e., n-butyl (S)-2-hydroxybutyrate) and 5 ml of dichloromethane to a 50 ml three-necked flask in sequence, stir until dissolved, cool to 0°C, add 0.155 g of pyridine, and dropwise add 0.528 g of trifluoromethanesulfonic anhydride to the resulting mixture while stirring. After the addition is complete, continue stirring and reacting for 30 min. After the reaction is completed, wash with water, collect the organic phase, spin dry, and separate the resulting concentrate by column chromatography using an adsorption column filled with 30 g of 200-300 mesh silica gel. The eluent is dichloromethane in an amount of about 300 ml to obtain a purified compound SME (i.e., n-butyl (S)-2-trifluoromethanesulfonyl hydroxybutyrate), which is dissolved in 10 ml of acetonitrile to prepare an acetonitrile solution containing the compound SME;

[0043] (2) 0.53 g of intermediate 2 was added to 10 ml of acetonitrile, and then 0.272 g of potassium carbonate was added. After stirring, the acetonitrile solution containing compound SME prepared in step (1) was added to the obtained mixture, and the reaction was stirred at room temperature for 14 minutes. After the reaction was completed, water was added to the obtained reaction solution to quench it, and the mixture was extracted with dichloromethane, washed with brine, dried over sodium sulfate, filtered and concentrated. The obtained concentrate was separated by column chromatography using an adsorption column filled with 30 g of 200-300 mesh silica gel. The eluent was n-heptane and ethyl acetate in a volume ratio of 2:1, and the amount was about 300 ml to obtain a colorless oil, namely intermediate 3 ((R)-2-(3-(benzo[d]oxazol-2-yl(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxybutyric acid butyl ester), with a yield of about 95% and a purity of 93.64%.

[0044] For this comparative example, the yield is 95%, which is relatively high, but the post-processing process is too cumbersome and requires two silica gel column separation and purification. In step (1), the product compound SME cannot be monitored by TLC and HPLC due to the lack of ultraviolet absorption, and a large amount of eluent is required for column washing, otherwise the yield of the product will be reduced; in addition, too much silica gel is filled in the adsorption column, which may cause adsorption decomposition, and also reduce the yield of the product. Only 0.3g of the reaction raw material compound SMD, when column chromatography is performed in the post-processing process, the adsorption column needs to be filled with 30g of 200-300 mesh silica gel, and the amount of silica gel is 100 times that of the reaction raw material compound SMD. The amount of silica gel is relatively high, and the silica gel cannot be reused, and a large amount of solid waste will be generated when expanding production. In the process of experimental operation, it is avoided that silica gel is inhaled into the human body, and the use of a large amount of silica gel will affect people's health. In addition, 300ml of eluent dichloromethane is also required, and a large amount of waste liquid will also be generated when expanding production. Currently, laboratories can only accept about 50g of crude product for column purification, while the column purification separation method is rarely used in factories, further limiting its industrial application.

[0045] In step (2), the product intermediate 3 also needs to be separated and purified by silica gel column. During column chromatography separation, the adsorption column needs to be filled with 30 g of 200-300 mesh silica gel and 300 ml of n-heptane and ethyl acetate in a volume ratio of 2:1. When expanding production, a large amount of solid waste and waste liquid will inevitably be generated, and the production cost will be greatly increased. The need to adopt a separation method of column purification further limits its industrial application.

[0046] Comparative Example 2

[0047] (1) Add 0.3 g of compound SMD (i.e., n-butyl (S)-2-hydroxybutyrate) and 5 ml of dichloromethane to a 50 ml three-necked flask in sequence, stir until dissolved, cool to 0°C, add 0.155 g of pyridine, and dropwise add 0.528 g of trifluoromethanesulfonic anhydride to the resulting mixture during stirring. After the dropwise addition is complete, continue stirring and reacting for 30 min. After the reaction is completed, wash with water, collect the organic phase, and spin dry to obtain compound SME (i.e., n-butyl (S)-2-trifluoromethanesulfonyl hydroxybutyrate), which is dissolved in 10 ml of acetonitrile to prepare an acetonitrile solution containing compound SME;

[0048] (2) 0.53 g of intermediate 2 was added to 10 ml of acetonitrile, and then 0.272 g of potassium carbonate was added. After stirring, the acetonitrile solution containing compound SME prepared in step (1) was added to the obtained mixture, and the reaction was stirred at room temperature for 14. After the reaction was completed, water was added to the obtained reaction solution to quench the reaction, and the mixture was extracted with dichloromethane, washed with brine, dried over sodium sulfate, and filtered and concentrated to obtain a colorless oil, namely intermediate 3 ((R)-2-(3-(benzo[d]oxazol-2-yl(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxybutyric acid butyl ester), with a yield of about 90% and a purity of 46.01%, which was lower than 50%, and the purity was too low.

[0049] For this comparative example, when preparing compound SME and intermediate 3 in step (1), silica gel column separation and purification were not used in the post-treatment process. The entire post-treatment process was relatively simple. The yield of the obtained intermediate 3 was about 90%, but the purity was less than 50%, which was too low and the impurity content was high, which was not conducive to the smooth progress of the subsequent reaction.

[0050] The yield and purity of the intermediate 3 in the embodiment and the comparative example were determined by HPLC. The results are shown in Table 1 below.

[0051] Among them, the chromatographic conditions of the HPLC detection method are as follows:

[0052]

[0053]

[0054] Table 1 Yield, purity and impurity content of product intermediate 3 in Examples and Comparative Examples

[0055]

[0056] As can be seen from Table 1, compared with Comparative Examples 1 and 2, the yield and purity of the intermediate 3 obtained in Examples 1-3 of the present invention are higher, and the content of related substances is lower. In the process of post-treatment, silica gel is added for stirring purification, extraction and suction filtration purification instead of two silica gel column separation and purification. The post-treatment process is simple, the yield and purity of the product are high, and the yield and purity are not less than 95%. The whole preparation method is simple, and there is no need to solve the problem of inevitably generating a large amount of solid waste and waste liquid due to two silica gel column separation and purification. The production cost can be greatly reduced, and it is suitable for industrial large-scale production.

[0057] The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, a person skilled in the art should understand that it is still possible to modify the technical solutions described in the aforementioned embodiments, or to perform equivalent replacements on some of the technical features therein. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.

Claims

1. A method for refining a Pemabet intermediate, characterized in that: It includes the following steps: (1) Compound SMD is dissolved in dichloromethane, pyridine is added at -5 to 5°C, trifluoromethanesulfonic anhydride is added dropwise to the resulting mixture while stirring, and after the addition is complete, the stirring reaction is continued. After the reaction is completed, silica gel is added to the resulting reaction solution, and the stirring time is 10 to 60 minutes. The solution is filtered and spin-dried to obtain compound SME, which is dissolved in acetonitrile to prepare an acetonitrile solution containing compound SME; (2) The intermediate 2, potassium carbonate and acetonitrile are uniformly mixed, and the acetonitrile solution containing the compound SME prepared in step (1) is added to the obtained mixture, and the mixture is stirred at room temperature for reaction. After the reaction is completed, water is added to the obtained reaction solution for quenching, extraction, washing, drying, suction filtration and concentration to obtain the intermediate 3. The specific synthetic route is as follows:

2. The method for refining the Pemabet intermediate according to claim 1, characterized in that: In step (1), the mesh size of the silica gel is 200-300; and the mass ratio of the compound SMD to the silica gel is 1:5-15.

3. The method for refining the Pemabet intermediate according to claim 2, characterized in that: In step (1), the mass ratio of the compound SMD to silica gel is 1:8-12, preferably 1:

10.

4. The method for refining the Pemabet intermediate according to claim 3, characterized in that: In step (1), pyridine is added at 0°C; in step (1), silica gel is added to the obtained reaction solution, and the stirring time is 30-60 minutes, preferably 30 minutes.

5. The method for refining the Pemabet intermediate according to claim 1, characterized in that: In step (1), the molar ratio of compound SMD to trifluoromethanesulfonic anhydride is 1:0.8-1.2; preferably 1:1.

0.

6. The method for refining the Pemabet intermediate according to claim 1, characterized in that: In step (1), the mass ratio of compound SMD to pyridine is 1:0.3-0.7; preferably 1:0.

52.

7. The method for refining the Pemabet intermediate according to claim 1, characterized in that: In step (2), the molar ratio of the compound SMD to the intermediate 2 is 1:0.5-0.9; preferably 1:0.

7.

8. The method for refining the Pemabet intermediate according to claim 1, characterized in that: In step (2), the mass ratio of the compound SMD to potassium carbonate is 1:0.6-1.2; preferably 1:0.

9.

9. The method for refining the intermediate of Pemabet according to claim 1, characterized in that: In step (2), the reaction time is 6-12 hours, preferably 8 hours.

10. The method for refining the intermediate of Pemabet according to claim 1, characterized in that: In step (2), water is added to the obtained reaction solution to quench the reaction, and the solution is extracted with dichloromethane, washed with brine, dried over sodium sulfate, filtered and concentrated to obtain Intermediate 3.

Citation Information

Patent Citations

  • Refining method of 3-[[2-benzoxazolyl [3-(4-methoxyphenoxy) propyl] amino] methyl] phenol

    CN116462638A

  • Process For Production of Optically Active Ppar-Activating Compound and Intermediate of the Same

    US20080194833A1

  • Optically active PPAR-activating compound intermediate and method for producing same

    US20090023944A1

Cited By

  • Method for preparing chiral butyrate units using enzymatic kinetic resolution and method for converting them to pemafibrate.

    JP2026169468A